Risk counseling and management in patients with lobular carcinoma in situ

American Journal of Surgery

Volumn 189, Issue 5 SPEC. ISS., 2005, Pages 610-615

  Garreau, Jennifer R ^a   Nelson, Joanne ^b   Look, Regan ^c   Walts, Deb ^d   Mahin, Diana ^d   Homer, Louis ^d   Johnson, Nathalie ^d   Clyde, J Courtney ^e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LEGACY EMANUEL HOSPITAL   (United States)

^c Northwest Cancer Specialists   (United States)

^d LEGACY GOOD SAMARITAN HOSPITAL   (United States)

^e NONE

Author keywords

Breast cancer; Counseling; Lobular carcinoma in situ

Indexed keywords

ADULT; ARTICLE; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; COUNSELING; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING;

EID: 18044396921     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.01.032     Document Type: Article

References (6)

1. F.W. Foote, F.E. Stewart Lobular carcinoma in situ, a rare form of mammary cancer Am J Pathol 17 1941 491 495
2. C.D. Haagensen, N. Lane, R. Lattes Lobular neoplasia (so called lobular carcinoma in situ) of the breast Cancer 42 1978 737 746
3. F. Gump, D. Kinne, G.F. Schwartz Current treatment for lobular carcinoma in situ Ann Surg Oncol 5 1998 33 36
4. D.L. Page, T.E. Kidd, W.D. Dupont Lobular neoplasia of the breast higher risk for subsequent invasive cancer predicted by more extensive disease Hum Pathol 22 1991 1232 1239
5. B. Fisher, J.P. Costantino, L. Wickerham Tamoxifen for prevention of breast cancer report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1998 1371 1388
6. S.R. Cummings, S. Eckert, K.A. Krueger The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation JAMA 281 1999 2189 2197